Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$165.67 - $199.94 $8.85 Million - $10.7 Million
-53,424 Reduced 96.34%
2,027 $342,000
Q4 2023

Jan 16, 2024

SELL
$151.44 - $200.09 $74 Million - $97.7 Million
-488,322 Reduced 89.8%
55,451 $10.9 Million
Q3 2023

Oct 27, 2023

SELL
$167.14 - $192.77 $2.01 Million - $2.31 Million
-12,009 Reduced 2.16%
543,773 $94.6 Million
Q2 2023

Jul 28, 2023

BUY
$160.94 - $186.23 $11.5 Million - $13.3 Million
71,614 Added 14.79%
555,782 $95.7 Million
Q1 2023

Apr 21, 2023

BUY
$145.48 - $175.02 $8.34 Million - $10 Million
57,303 Added 13.42%
484,168 $80.6 Million
Q4 2022

Feb 01, 2023

BUY
$131.14 - $157.47 $3.81 Million - $4.58 Million
29,061 Added 7.31%
426,865 $62.6 Million
Q3 2022

Nov 14, 2022

BUY
$148.29 - $182.55 $39 Million - $48 Million
262,823 Added 194.71%
397,804 $59 Million
Q2 2022

Jul 13, 2022

BUY
$155.97 - $200.09 $6.7 Million - $8.59 Million
42,931 Added 46.64%
134,981 $23.2 Million
Q1 2022

Apr 29, 2022

SELL
$181.39 - $234.03 $265 Million - $341 Million
-1,459,164 Reduced 94.07%
92,050 $17.4 Million
Q4 2021

Jan 24, 2022

SELL
$193.69 - $247.03 $3.12 Million - $3.98 Million
-16,127 Reduced 1.03%
1,551,214 $349 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $31 Million - $34.3 Million
-163,808 Reduced 9.46%
1,567,341 $304 Million
Q2 2021

Aug 12, 2021

BUY
$155.9 - $187.99 $1.65 Million - $1.99 Million
10,606 Added 0.62%
1,731,149 $323 Million
Q1 2021

May 14, 2021

BUY
$144.0 - $169.39 $179 Million - $211 Million
1,243,384 Added 260.58%
1,720,543 $271 Million
Q4 2020

Feb 11, 2021

BUY
$157.07 - $174.35 $1.42 Million - $1.57 Million
9,028 Added 1.93%
477,159 $79 Million
Q3 2020

Nov 16, 2020

BUY
$137.1 - $165.37 $6.21 Million - $7.49 Million
45,279 Added 10.71%
468,131 $77.4 Million
Q2 2020

Aug 13, 2020

BUY
$111.92 - $142.53 $15.3 Million - $19.4 Million
136,298 Added 47.56%
422,852 $57.9 Million
Q1 2020

May 13, 2020

SELL
$92.66 - $144.94 $979,138 - $1.53 Million
-10,567 Reduced 3.56%
286,554 $33.7 Million
Q4 2019

Feb 10, 2020

BUY
$116.25 - $133.25 $3.46 Million - $3.96 Million
29,733 Added 11.12%
297,121 $39.3 Million
Q3 2019

Nov 08, 2019

SELL
$112.57 - $128.43 $2.8 Million - $3.2 Million
-24,912 Reduced 8.52%
267,388 $33.3 Million
Q2 2019

Aug 13, 2019

SELL
$97.98 - $114.28 $4.36 Million - $5.08 Million
-44,455 Reduced 13.2%
292,300 $33.2 Million
Q1 2019

May 14, 2019

BUY
$81.56 - $100.67 $11.1 Million - $13.7 Million
136,070 Added 67.8%
336,755 $33.9 Million
Q4 2018

Feb 06, 2019

BUY
$79.28 - $95.27 $10.2 Million - $12.2 Million
128,185 Added 176.81%
200,685 $17.2 Million
Q3 2018

Nov 09, 2018

BUY
$83.5 - $93.23 $375,750 - $419,535
4,500 Added 6.62%
72,500 $6.64 Million
Q2 2018

Aug 10, 2018

BUY
$79.9 - $89.2 $5.43 Million - $6.07 Million
68,000 New
68,000 $5.79 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $83.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Australian Super Pty LTD Portfolio

Follow Australian Super Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Australian Super Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Australian Super Pty LTD with notifications on news.